299. Cystic fibrosis Clinical trials / Disease details


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02444234
(ClinicalTrials.gov)
July 20156/5/2015Pharmacokinetics of Tedizolid Phosphate in Cystic FibrosisSteady-State Pharmacokinetics of Tedizolid in Plasma and Sputum of Patients With Cystic FibrosisCystic FibrosisDrug: Tedizolid PO;Drug: Tedizolid IVUniversity of Southern CaliforniaMerck Sharp & Dohme Corp.Completed18 YearsN/AAll11Phase 4United States
2EUCTR2011-000130-11-IT
(EUCTR)
25/07/201105/03/2012Clinical trials in rare diseases: therapeutic alternative to the use of oral corticosteroids in patients with cystic fibrosis underwent double lung transplantation.Clinical trials in rare diseases: therapeutic alternative to the use of oral corticosteroids in patients with cystic fibrosis underwent double lung transplantation. Double lung transplantation in patients with Cystic Fibrosis
MedDRA version: 14.1;Level: PT;Classification code 10011763;Term: Cystic fibrosis lung;System Organ Class: 10010331 - Congenital, familial and genetic disorders
MedDRA version: 14.1;Classification code 10025127;Term: Lung transplant;System Organ Class: 10042613 - Surgical and medical procedures;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Product Name: Dexamethasone sodium phosphate 250 mg/10 ml solution
Product Code: NA
INN or Proposed INN: Dexamethasone
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMANULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy